PRKAA2 and colorectal carcinoma: Intriguingly, SMYD3-AMPK interaction was confirmed in several gastrointestinal cancer cell lines (CRC, GC, HCC, PC), supporting the involvement of SMYD3 in gastrointestinal cancer-related metabolism.